I'm not saying they should put our phoney PR's to jack the
I'm not saying they should put our phoney PR's to jack the share price up. Not at all. What I'm saying is they should get off their bum and start working harder so they can meet the deadlines they've given us. For example, pick your subjects for studies properly the first time to avoid anyone getting ejected due to factors like doing drugs, getting pregnant etc.
I don't mind waiting another few years even to get the share price back up again. Not at all. But my issue is if they say something, they should work very hard to keep to it, otherwise people start to lose confidence. It's like the guy that owe's you money and tells you he'll pay you next week. But then he tells you he can't and it'll be another week. And then of course, something came up and it'll be next week. After the fourth or fifth time, you'll start to wonder if you'll ever get your money.
They should seriously come out and say, you guys won't see anything until 1 year later. Then if they complete it within 6 months, everybody will be happy. For us, everything is always one quarter away. But when that quarter comes, it's another quarter. It used to be we were thinking safety study was supposed to be finished sometime last year. Then it's Q1 of this year. Now it's Q2. Seriously, just finish one thing once!
Humour me for a second. Just let this thought pass through your mind. Imagine if next quarter they issue another PR that the safety study will be completed by Q3. What will your guys' thoughts be?
According to what they've said, the cream and formulation is done. It works. They just have to back up the results with studies. Fair enough. But adding more qualified people won't allow big things to happen. Getting those studies done will.
I'm content to waiting much longer if I see ONE THING of substance. The longer that wait becomes, the more unhappy I will be with this company, no matter how fantastic they are.
OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...
Continue Reading
Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...
Continue Reading
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
Top 5 Most Recently Viewed Articles
Key Information Overview The disclosure notice from Rathbones Group Plc reflects its significant stake in Renewi Plc, which comprises £1 ordinary shares. This transparency is essential for investors looking to understand potential influences on the market. Discloser Details Rathbones Group Plc has publicly announced their holdings, demonstrating accountability and...
Continue Reading
Waystar's Innovative Solutions Lead to Industry Recognition Waystar has gained significant accolades, being recognized as a leading healthcare payments software platform. This acknowledgment highlights the unique value Waystar brings to the healthcare industry, particularly in addressing nearly half a trillion dollars in administrative waste. Commitment to Combatting...
Continue Reading
Edible Garden Regains Nasdaq Compliance Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW) has exciting news to share with its investors. Recently, Edible Garden announced that it has successfully regained compliance with the minimum bid price requirement set forth by Nasdaq, a significant achievement that reinforces the...
Continue Reading
Landsbankinn hf. Completes a Successful Covered Bond Auction Landsbankinn hf., a prominent financial institution in Iceland, has recently concluded a successful covered bond auction, showcasing strong investor interest. The auction attracted bids with yields ranging from 7.29% to 3.70%, reflecting competitive terms for investors. Details of the Auction During this event,...
Continue Reading
Join the Fight for Justice with Skye Bioscience, Inc. In today's fast-paced financial world, investors need to stay informed and proactive. This is especially true for those who invested in Skye Bioscience, Inc. (NASDAQ: SKYE). As recent developments unfold, it is essential for investors to understand the legal landscape and their rights regarding their investments. The...
Continue Reading